<p>Schematic representation of DSS-induced colitis in SAMP and AKR mice (A). Body weight loss (B), expressed as the percentage of initial body weight, * <i>P</i> < 0.05; n ≥ 6 and DAI scores (C) were higher after chronic DSS-colitis induction in SAMP compared to AKR controls. * <i>P</i> < 0.05, ** <i>P</i> < 0.01; n ≥ 6. High-resolution endoscopic images with white light and NBI of distal colons together with endoscopic scores (D) (*** <i>P</i> = 0.0006; n ≥ 6) and representative photomicrographs of colon sections stained with H&E as well as total inflammatory scores (E) (* <i>P</i> = 0.0016; n ≥ 6) are shown for AKR and SAMP mice.</p
<p>FXIII<sup>−/−</sup> mice (◯) challenged with DSS develop significantly worse clinical signs of di...
<p>WT mice were treated continuously with ABX and fed PD or TD for 2% DSS treatment. (A) Percent ori...
<p>(A) Colon weight and (B) Colon length of miR-21 KO and WT mice were measured on day 7 or time of ...
<p>High resolution endoscopic images of distal colons following AOM/DSS administration revealed rema...
<p><b>A.</b> Schema of a DSS treatment experiment. DSS at the concentration of 3% was administered i...
<p>Colitis was induced in Ly49E WT and Ly49E KO mice by administration of DSS in drinking water for ...
<p>(A) Mouse body weight changes during DSS treatment compared to that of control animals (drinking ...
<p>(A) Change in body weight. Percent weight loss from baseline (y-axis) is plotted versus time post...
<p>Colitis was induced in wild-type, MCL<sup>−/−</sup> and DCIR<sup>−/−</sup> mice by adding 3% DSS ...
<p>To induce colitis, six week old WT (n = 24) and MCH-KO (n = 32) mice, both of the APCmin backgrou...
(A) The body weight loss of mice in each group for 8 consecutive days (n = 6). (B) The change of dis...
<p>Balb/c mice were offered distilled water (filled circles), or distilled water with 3% DSS orally ...
<p>(A) Representative photomicrographs of H&E staining on distal colon of FVB-N mice after DSS treat...
Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cance...
<div><p>Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorect...
<p>FXIII<sup>−/−</sup> mice (◯) challenged with DSS develop significantly worse clinical signs of di...
<p>WT mice were treated continuously with ABX and fed PD or TD for 2% DSS treatment. (A) Percent ori...
<p>(A) Colon weight and (B) Colon length of miR-21 KO and WT mice were measured on day 7 or time of ...
<p>High resolution endoscopic images of distal colons following AOM/DSS administration revealed rema...
<p><b>A.</b> Schema of a DSS treatment experiment. DSS at the concentration of 3% was administered i...
<p>Colitis was induced in Ly49E WT and Ly49E KO mice by administration of DSS in drinking water for ...
<p>(A) Mouse body weight changes during DSS treatment compared to that of control animals (drinking ...
<p>(A) Change in body weight. Percent weight loss from baseline (y-axis) is plotted versus time post...
<p>Colitis was induced in wild-type, MCL<sup>−/−</sup> and DCIR<sup>−/−</sup> mice by adding 3% DSS ...
<p>To induce colitis, six week old WT (n = 24) and MCH-KO (n = 32) mice, both of the APCmin backgrou...
(A) The body weight loss of mice in each group for 8 consecutive days (n = 6). (B) The change of dis...
<p>Balb/c mice were offered distilled water (filled circles), or distilled water with 3% DSS orally ...
<p>(A) Representative photomicrographs of H&E staining on distal colon of FVB-N mice after DSS treat...
Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cance...
<div><p>Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorect...
<p>FXIII<sup>−/−</sup> mice (◯) challenged with DSS develop significantly worse clinical signs of di...
<p>WT mice were treated continuously with ABX and fed PD or TD for 2% DSS treatment. (A) Percent ori...
<p>(A) Colon weight and (B) Colon length of miR-21 KO and WT mice were measured on day 7 or time of ...